Literature DB >> 11687713

Central nervous system: review of clinical use of contrast media.

V M Runge1, L R Muroff, J R Jinkins.   

Abstract

The clinical utility of intravenous contrast administration for magnetic resonance imaging in neoplastic disease of the brain, non-neoplastic disease of the brain, and in disease of the spine is reviewed. Magnetic resonance imaging (MRI) is the modality of choice for the evaluation of most suspected intracranial and spinal pathology. Contrast use substantially improves lesion detection and differential diagnosis. Applications are discussed in neoplastic disease, infection, vascular disorders, demyelinating disease, and trauma (specifically including in the spine disk herniation). Gadolinium chelates play as important a role in magnetic resonance imaging as do iodinated agents in computed tomography. Contrast administration facilitates time-efficient and cost-effective diagnosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687713     DOI: 10.1097/00002142-200108000-00003

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  9 in total

Review 1.  MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice.

Authors:  M Essig; N Anzalone; S E Combs; À Dörfler; S-K Lee; P Picozzi; A Rovira; M Weller; M Law
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-20       Impact factor: 3.825

2.  Hexylether derivative of pyropheophorbide-a (HPPH) on conjugating with 3gadolinium(III) aminobenzyldiethylenetriaminepentaacetic acid shows potential for in vivo tumor imaging (MR, Fluorescence) and photodynamic therapy.

Authors:  Joseph A Spernyak; William H White; Manivannan Ethirajan; Nayan J Patel; Lalit Goswami; Yihui Chen; Steven Turowski; Joseph R Missert; Carrie Batt; Richard Mazurchuk; Ravindra K Pandey
Journal:  Bioconjug Chem       Date:  2010-05-19       Impact factor: 4.774

3.  Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents.

Authors:  Ian R Corbin; Hui Li; Juan Chen; Sissel Lund-Katz; Rong Zhou; Jerry D Glickson; Gang Zheng
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

Review 4.  Improving lesion detection and visualization: implications for neurosurgical planning and follow-up.

Authors:  Piero Picozzi; Miles A Kirchin
Journal:  Neuroradiology       Date:  2007-07       Impact factor: 2.804

Review 5.  Multimodal MRI contrast agents.

Authors:  Luca Frullano; Thomas J Meade
Journal:  J Biol Inorg Chem       Date:  2007-07-21       Impact factor: 3.862

Review 6.  Contrast-enhanced magnetic resonance imaging in pediatric patients: review and recommendations for current practice.

Authors:  Ravi Bhargava; Gabriele Hahn; Wolfgang Hirsch; Myung-Joon Kim; Hans-Joachim Mentzel; Oystein E Olsen; Eira Stokland; Fabio Triulzi; Elida Vazquez
Journal:  Magn Reson Insights       Date:  2013-10-20

7.  Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study.

Authors:  Juan E Gutierrez; Martin Rosenberg; Jörg Seemann; Josy Breuer; Daniel Haverstock; Jacob Agris; Thomas Balzer; Nicoletta Anzalone
Journal:  Magn Reson Insights       Date:  2015-04-07

8.  A Japanese, Multicenter, Open-label, Phase 3 Study to Investigate the Safety and Efficacy of Gadobutrol for Contrast-enhanced MR Imaging of the Central Nervous System.

Authors:  Akio Tanaka; Tomohiko Masumoto; Haruyasu Yamada; Masayo Kurauchi; Josy Breuer
Journal:  Magn Reson Med Sci       Date:  2015-12-21       Impact factor: 2.471

Review 9.  Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme.

Authors:  L Nam; C Coll; L C S Erthal; C de la Torre; D Serrano; R Martínez-Máñez; M J Santos-Martínez; E Ruiz-Hernández
Journal:  Materials (Basel)       Date:  2018-05-11       Impact factor: 3.623

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.